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Abstract We studied the effects of thapsigargin on the forma- 
tion of the phosphorylated intermediates (E~Ps) of endoplasmic 
reticulum Ca2÷-ATPases in microsomes from bovine adrenal me- 
dulla. When submicrosomal fractions were separated on a sucrose 
gradient, two components of 100 kDa Ca2÷-ATPase E~P display- 
ing distinct subeellular distributions were resolved. The first com- 
ponent was defined by Ca2÷-induced protection against thapsi- 
gargin inhibition. The second component did not display such 
protection, with a 3 orders of magnitude difference in thapsi- 
gargin inhibitory potency towards the 2 components. In the ab- 
sence of Ca 2+, both E~P components were highly sensitive to 
thapsigargin inhibition, revealing the presence of high-affinity 
thapsigargio-binding sites characteristic of SERCA ATPases. 
These data demonstrate a new level of molecular heterogeneity 
among Ca2+-ATPases of endoplasmic reticulum, and provide the 
first evidence of differential subcellular localization of individual 
Ca 2+ pump subtypes in cells of neural origin. 
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1. Introduction 
In eukaryotic cells the concentration of free Ca 2÷ in the 
lumen of endoplasmic reticulum (ER) exceeds that of cytosol 
by 34  orders of magnitude [1,2]. The maintenance of Ca 2+ 
gradient between the ER lumen and the cytosol depends on the 
activity of Ca 2+ pumping ATPases. The best characterized fam- 
ily of ER CaZ+-ATPases (the SERCA family) consists of at least 
5 structurally distinct isoenzymes [3], arising from 3 genes 
through the process of differential processing of the corre- 
sponding primary transcript mRNAs.  However, additional 
structurally distinct family members appear to exist [4], suggest- 
ing that the full extent of the heterogeneity among SERCA 
pumps has not yet been explored. The characteristic tissue 
distribution [3], as well as the occurrence of multiple SERCA 
isoenzymes in one cell type [5-7] suggest functional implications 
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of this heterogeneity. Such heterogeneity would seem of partic- 
ular interest in neurally derived cells, showing complex intracel- 
lular Ca 2+ signalling patterns. Chromaffin cells of adrenal me- 
dulla represent one such cell type [8-9]. We have used thapsi- 
gargin, a potent and selective inhibitor of SERCA ATPases 
[10,I 1], to study the heterogeneity of SERCA enzymes in these 
cells. A striking difference in the sensitivity to thapsigargin, 
corresponding to a clearly distinct subcellular distribution pro- 
files, could be demonstrated for two of the phosphorylated 
intermediates of SERCA pumps. 
2. Materials and methods 
Thapsigargin was a generous gift from Dr. S.B. Christensen (The 
Royal Danish School of Pharmacy). The IID8 monoclonal antibody 
was from Affinity Bioreagents, Neshanic Station, N J, USA. 
Preparation of bovine adrenal medulla microsomes and submicro- 
somal fractions, and isolation of chromaffin cells were performed as 
described earlier [12]. 
To measure the formation of Ca2+-ATPase phosphorylated interme- 
diates (Ca2*-ATPase E ~ Ps), the phosphorylation assay was carried out 
at 0°C, using 50-60 or 5/tg membrane protein (in the latter case, 
1 mg/ml bovine serum albumin was included in the medium to act as 
a carrier under acid precipitation). The final assay mixture (volume 100 
/~1) contained 40 mM TES (pH 7.0), 120 mM KCI, 0.1 mM CaCI2, 
[y-32p]ATP 50 nM (approximately 300 Ci/mmol). In some experiments, 
MgC12 (5 mM) or various concentrations of thapsigargin were included 
in the assay. Thapsigargin was added as a 50-fold concentrated solution 
in dimethylsulfoxide (DMSO). Equivalent amount of DMSO was 
added to the control samples. (This amount of DMSO did not affect 
the formation of the Ca2+-ATPase phosphorylated intermediate.) For 
the standard assay, thapsigargin was added to the membranes resus- 
pended in the assay mixture without [y-32p]ATP. For the reversed 
assay, thapsigargin was added to the membranes resuspended in the 
assay mixture containing 0.5 mM EGTA instead of CaC12, and no 
[y-32P]ATP. In all cases, the membranes were incubated with thapsi- 
gargin for 10 rain before starting the phosphorylation by addition of 
[y-32p]ATP without (standard assay), or with enough CaC12 to obtain 
final Ca 2+ concentration 0.6 mM in the presence of 0.5 mM EGTA 
(reversed assay). (In the absence of thapsigargin, the amount of E~P 
formed was identical under either standard or reversed assay condi- 
tions.) The phosphorylation was stopped after 20 s using 100 ,ul of 
ice-cold 12% trichloroacetic acid/20 mM H3PO 4. The mixture was 
allowed to rest on ice for 10 min, followed by centrifugation at 
20,000 x g for 15 min. The pellets were resuspended in the electropho- 
resis sample buffer. 
In some experiments, 5/tl of 1 mg/ml trypsin (Sigma Type XIII, 
TPCK treated, 11,000 units/mg) in TES 40 mM (pH 7.0) were added 
to the assay mixture to carry out partial digestion of Ca2+-ATPase 
before the phosphorylation. The digestion was stopped after 15 rain by 
5 ¢tl of soybean trypsin inhibitor (5 mg/ml). 
SDS polyacrylamide gel electrophoresis (SDS PAGE) under acid 
conditions (to preserve Ca2+-ATPase E~P) and immunoblotting were 
carried out as described earlier [12,13]. After staining and drying, the 
gels were autoradiographed on the ECL Hyperfilm (Amersham). Typ- 
ical exposure lasted 16-24 h. For a quantitative valuation of the 
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amount of phosphorylated intermediate, he phosphoprotein-contain- 
ing gel pieces were cut out under the guidance of the autoradiogram and 
their radioactivity determined by scintillation counting. Protein was 
determined by the fluorescamine method [14]. 
2.1. Calculations 
Total Ca2+-ATPase E~P was defined as the E~P measured in the 
absence of thapsigargin. The apparently thapsigargin-insensitive E~P 
component was defined as the activity measured inthe standard assay 
in the presence of 1/zM thapsigargin. The thapsigargin-sensitive E~P
component was calculated as the difference between the total and the 
apparently thapsigargin-insensitive components. For each submicro- 
somal fraction, the relative specific activity (RSA) for any of the Ca 2÷- 
ATPase E~P components ( otal, apparently thapsigargin-insensitive or 
thapsigargin-sensitive) was calculated as a ratio between the component 
activity measured in this fraction, and the corresponding activity due 
to an equivalent amount of protein in total microsomes (P3 fraction 
loaded on the gradient). 
3. Results 
We studied the formation of Ca2*-ATPase phosphorylated 
intermediates (E ~ P) [15,16] in a preparation fmicrosomes from 
bovine adrenal medulla described earlier [12,13]. The micro- 
somes were incubated with [~'-32p]ATP, followed by PAGE in 
an acid gel system and autoradiography. Fig. 1 shows that in 
the presence of Mg 2÷ 5 mM and Ca 2÷ 100/aM, 2 phosphorylated 
proteins were detected with molecular masses of 116 and 100 
kilodaltons (kDa), respectively. When Ca 2÷ was omitted from 
the assay, the phosphorylation f the 100 kDa protein, but not 
of the 116 kDa protein, was abolished. The phosphorylation f 
100 kDa, but not of the 116 kDa protein, was partly (standard 
assay; Figs. 1A and 2) or fully (reversed assay; Figs. 1B and 4) 
inhibited by thapsigargin. The Ca2+-ATPase portion essential 
for thapsigargin binding (the M3 transmembrane segment) is
conserved among the SERCA-type, as opposed to other P-type 
ATPases (e.g. plasma membrane Ca2+-ATPase or Na+,K ÷- 
ATPase) [17]. Therefore, we conclude that the 100 kDa phos- 
phoprotein most likely represents an E ~P form of SERCA-type 
Ca2+-ATPase, as supported further by the tryptic digestion pat- 
tern of the 100 kDa phosphoprotein (Fig. 5A and section 4). 
About 80% of the adrenal medulla mass is composed of 
chromaffin cells [18], strongly suggesting that these cells con- 
tributed the major part of the E~P forms observed in the total 
microsomes and their subfractions. To test this suggestion, the 
microsomes were prepared from isolated chromaffin cells 
rather than from entire medulla. In these cell-derived micro- 
somes, the presence of the autophosphorylated proteins of 116 
and 100 kDa, the Ca 2÷ dependence of the 100 kDa, but not the 
116 kDa, as well as partial inhibition by thapsigargin ofthe 100 
kDa, but not the 116 kDa phosphoprotein, were all demon- 
strated in the same manner as described above for the whole 
adrenal medulla microsomes (not shown). 
Omission of Mg 2÷ (in the absence or presence of thapsi- 
gargin) did not affect the phosphorylation of the 100 kDa 
protein, while phosphorylation f the 116 kDa was strongly 
inhibited in the absence of Mg 2÷ (compare for instance Figs. 1 
and 2). This behavior of the 100 kDa phosphoprotein is con- 
sistent with the known properties of ER Ca2+-ATPase E~P 
formation [19,20]. Since the absence of a phosphorylated pro- 
tein at 116 kDa allowed a more accurate measurement of the 
radioactivity selectively associated with the 100 kDa E~P, we 
routinely omitted Mg 2÷ in the further analysis of the 100 kDa 
phosphorylated intermediate. 
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Fig. 1. Differential inhibition by thapsigargin ofthe formation of 100 
kDa phosphorylated intermediate of Ca2*-ATPase in adrenal medulla 
microsomes under standard (A) or reversed (B) assay conditions. Mi- 
crosomes were phosphorylated under standard (A) or reversed (B) 
assay conditions (defined in section 2) in the presence of5 mM Mg 2÷, 
and analyzed by acid SDS-PAGE and autoradiography. The presence 
or absence of Ca 2+ or thapsigargin (Tg) in the phosphorylation assay 
is indicated (double determinations, 60/.tg protein/lane). (Results repre- 
sent 4 microsome preparations.) 
The distribution of the 100 kDa E~P in the submicrosomal 
fractions was analyzed using the isopycnic, discontinuous su- 
crose gradient characterized recently [12]. The distribution was 
broad, indicating the presence of Ca2+-ATPase in ER subcom- 
partments spanning different buoyant densities (Fig. 2A,C). 
The E~P was not detected in fraction 1, and was only barely 
detectable in fraction 8. Fraction 1 represents soluble proteins 
which have not entered the gradient. Fraction 8 was earlier 
found to exhibit a weak, thapsigargin-sensitive ATP-dependent 
45Ca2÷ uptake [12]. 
In the standard phosphorylation assay, a striking variation 
was observed in the sensitivity of the 100 kDa E~P to 1/aM 
thapsigargin among the microsomal subfractions separated on 
the gradient (Fig. 2A,B). Very small inhibitory effect was ob- 
served in fractions 4and 5. Fractions 2and 7 showed an almost 
complete inhibition of 100 kDa E -P  formation in the presence 
of thapsigargin, while fraction 6 displayed an intermediate s n- 
sitivity. The presence of a range of thapsigargin sensitivities in
the individual fractions is consistent with the partial inhibition 
observed in the total microsomes (Figs. 1A, 2B). 
When the intensities of 100 kDa E ~ P were expressed as RSA 
distribution (see Methods for definitions of E~P RSA and its 
components) across the gradient, he total E~P profile (Fig. 2C) 
could be resolved into two distinct components (Fig. 2D): the 
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Fig. 2. Distribution of the 100 kDa phosphorylated intermediates of Ca2+-ATPase following fractionation of adrenal medulla microsomes on a 
discontinuous sucrose gradient, and the differential sensitivity of microsomal subfractions to inhibition by thapsigargin. Separated fractions were 
phosphorylated under standard assay conditions in the absence of Mg 2÷ and in the absence (A) or presence (B) of 1/.tM thapsigargin. The RSA 
distribution of the total (C), apparently thapsigargin-insensitive (D, A)and thapsigargin-sensitive (D, *) components of the 100 kDa phosphorylated 
intermediate of Ca2+-ATPase was determined asdescribed insection 2. Fraction umbers are indicated under the autoradiograms (A,B) and graphs 
(C,D), with P3 representing total microsomes. (A and B) 60 pg of protein was run on each lane (fraction 1 never showed any phosphoproteins and 
is not included). (C and D) Points and bars indicate means and S.E.M. values, respectively, from 4 preparations. 
apparently thapsigargin-insensitive component, peaking in 
fractions 4and 5, and a biphasic, thapsigargin-sensitive compo- 
nent with a peak in fraction 6 and a broad shoulder in fractions 
3 and 4. 
The extent of the difference between the sensitivities of the 
100 kDa E ~ P in fraction 7(predominantly containing the sensi- 
tive E~ P component) and fraction 4(predominantly containing 
the apparently insensitive E -P  component) is illustrated inFigs. 
3 and 4. It may be seen from Fig. 4 that about 75% decline in 
E ~ P was caused by 10 nM thapsigargin in fraction 7. In contrast, 
only about 20% decline of the E~P amount in response to 10 
nM, and only 40% decline in response to 10,000 nM thapsi- 
gargin, was measured in fraction 4. 
The lack of sensitivity to thapsigargin i hibition displayed by 
100 kDa E~P in some of the submicrosomal fractions could be 
removed by reversing the order of Ca 2÷ and thapsigargin addi- 
tions to the membranes in the phosphorylation assay (Figs. 1B 
and 4). When adrenal medulla microsomes were preincubated 
with thapsigargin i the absence of added Ca 2+ for 10 min 
before adding Ca 2÷ and [y-3zp]ATP (reversed assay, see section 
2), a complete inhibition of the 100 kDa E~P formation oc- 
curred. Fig. 4 shows that under these conditions, full inhibition 
was observed at 1 nM or 10 nM thapsigargin, using 5 or 50/.tg 
membrane protein in the assay, respectively. Therefore, Fig. 4 
shows that the apparent inhibitory potency of thapsigargin 
depended on the amount of protein in the phosphorylation 
assay. This observation is consistent with the high-affinity [21], 
stoichiometric nteraction between CaZ+-ATPase and thapsi- 
gargin [22,23]. Thus, under the reversed phosphorylation assay 
conditions, the thapsigargin-binding site appeared accessible in 
all of the Ca2+-ATPases contributing to the formation of 100 
kDa E~P in adrenal medulla microsomes. A comparison of the 
effects of thapsigargin i  fractions 4and 7 under the conditions 
of the reversed assay is shown in Fig. 4 (symbols: clear triangles 
and squares). Here, the wide disparity between thapsigargin 
sensitivities of the 2 fractions is abolished, in contrast o the 
situation in the standard assay (Fig. 4, symbols: filled triangles 
and squares). The fact that complete inhibition was seen under 
the conditions of Fig. 4 in the range of 1-10 nM thapsigargin 
proves that in Fig. 2, the variable inhibition across the gradient 
in the presence of 1/.tM thapsigargin cannot be ascribed to the 
presence of excess CaZ+-ATPase, relative to the inhibitor, in 
those fractions howing lack of inhibition. 
Some of the isoenzymes of SERCA ATPases may be distin- 
guished by characteristic patterns of tryptic digestion fragments 
on SDS-gels (see section 4). In view of the novel pattern of 
thapsigargin sensitivity of the 100 kDa E -P  in the microsomal 
subfractions of adrenal medulla, we carried out tryptic diges- 
tion followed by phosphorylation from [?-32p]ATP in the pres- 
ence or absence of thapsigargin gradient fractions 4 and 7, 
under the conditions allowing the expression of the apparent 
thapsigargin insensitivity (the standard assay conditions). 
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Fig. 3. The extent of the difference between the susceptibility othapsi- 
gargin inhibition of the 100 kDa Ca2+-ATPase phosphorylated interme- 
diates in fraction 7 (A) and fraction 4 (B) under standard assay condi- 
tions (in the absence of Mg2*). For each indicated thapsigargin (Tg) 
concentration, 60 #g of fraction protein was analyzed. 
Fig. 5A shows that the 56 and 35 kDa phosphorylated frag- 
ments were generated by trypsin digestion in both fractions. 
The differential sensitivity of 100 kDa E ~ P to thapsigargin i hi- 
bition in these 2 fractions was mimicked by both of these tryptic 
fragments, with little inhibition visible in fraction 4 and a strong 
inhibition in fraction 7. In addition, a rather weak, 80 kDa, 
thapsigargin-sensitive E ~ P fragment was apparent in fraction 7. 
(In separate xperiments, the 48 kDa fragment visible between 
the 56 and 35 kDa fragments was shown to originate from the 
116 kDa phosphoprotein, rather than from the 100 kDa Ca 2÷- 
ATPase E~P.) 
Fig. 5A shows also an example of a strong film darkening 
characteristic of fraction 7, presumably due to high molecular 
weight, phosphorylatable proteins poorly resolved in the acid 
SDS-PAGE system used. Since this effect was always independ- 
ent of the presence of Ca 2+ or thapsigargin, the darkened area 
was not considered to contain any CaZ+-ATPase E~P forms. 
Since the 56-35 kDa tryptic digestion fragments have been 
shown to originate from the SERCA 2-type Ca2+-ATPases ( ee 
section 2), we probed the immunoblots of gradient fractions 
using the IID8 monoclonal antibody specific for this class of 
pumps [24]. Specific staining was detected corresponding to 
molecular mass 100 kDa in fractions 3-8 across the gradient, 
and is illustrated for fractions 4 and 7 in Fig. 5B, for compar- 
ison with the digestion-phosphorylation data in Fig. 5A. 
4. Discussion 
Two novel aspects of the heterogeneity of SERCA enzymes 
emerge from this study: (1) the E ~ P forms of these nzymes may 
be discerned showing widely differing susceptibilities to thapsi- 
gargin inhibition; (2) the two E~P forms with different hapsi- 
gargin sensitivities clearly followed different subcellular parti- 
cles on an isopycnic sucrose gradient, thus revealing their dif- 
ferent tocalizations within chromaffin cell ER system. 
Incubation of adrenal medulla microsomes with [T-32p]ATP 
resulted in a phosphorylation f 116 and 100 kDa proteins (Fig. 
1). However, phosphorylation f the 116 kDa protein was not 
affected by the removal of Ca 2÷, was strongly dependent on the 
presence of Mg 2*, and (in some experiments) appeared to be 
only slightly inhibited by high (1 #M) concentration of thapsi- 
gargin, even under the conditions of maximally effective thapsi- 
gargin inhibition of 100 kDa SERCA phosphorylated interme- 
diates (reversed assay, see Fig. 1B and discussion below). For 
these reasons, the 116 kDa phosphorylated protein cannot rep- 
resent the E ~ P form ofa SERCA pump and was not investigated 
further. (In our previous work [12], a 116 kDa protein in adre- 
nal medulla microsomes was shown to react with a monoclonal 
antibody (Y/1F4) raised against skeletal muscle Ca>-ATPase. 
However, this Y/1F4-reactive protein was strongly enriched in 
fractions 6-8 of the sucrose gradient, and was missing in frac- 
tions 14  [12]. In contrast, the 116 kDa phosphoprotein ob- 
served in this work was broadly distributed throughout frac- 
tions 2-8 (not shown).) 
The differential thapsigargin sensitivity (Figs. 2,3,4,5) was 
only apparent under assay conditions where binding of thapsi- 
gargin to ATPase in the absence of Ca 2÷ was prevented (termed 
standard assay conditions). Thus, for the E~P species particu- 
larly enriched in microsomal subfractions 4 and 5, preincuba- 
tion with Ca 2÷ afforded a protection against hapsigargin hi- 
bition. If thapsigargin was allowed to bind to ATPase in the 
absence of Ca 2÷ (reversed assay), equally strong inhibition of 
E~P formation was observed in all fractions (Figs. 1B and 4). 
Under these conditions, the potent inhibitory effect of thapsi- 
gargin strongly indicated that in all the fractions, the 100 kDa 
E -P  did in fact represent a SERCA type Ca2÷-ATPase [10,17]. 
A protection of skeletal muscle (SERCA 1) Ca2÷-ATPase phos- 
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Fig. 4. Quantitation ofthapsigargin-induced inhibition of the 100 kDa 
Ca2+-ATPase phosphorylated intermediate formation under standard 
(v,I) and reversed UT,E3,e,o) assay conditions. Symbols 'v,v' and 're,E3' 
represent fractions 4 and 7, respectively. Symbols 'e,o' represent total 
microsomes. In the phosphorylation assay, either 50 #g (v,m,e) or 5 #g 
(%D,o) of protein was used. Means_+S.E.M. from 34 microsome prep- 
arations are illustrated. 
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Fig. 5. Differential inhibition by thapsigargin of the phosphorylation f tryptic fragments of 100 kDa Ca2+-ATPase in submicrosomal fractions 4 
and 7 under standard assay conditions (A) and the presence of a SERCA 2-type immunoreactivity n these fractions (B). (A) Partial tryptic digestion 
(Trp) prior to phosphorylation (i the absence of Mg 2+) was carried out in the absence or presence of thapsigargin (Tg), as described in section 2. 
56 kDa and 35 kDa fragments (fractions 4and 7) and 80 kDa fragment (fraction 7) are indicated by clear arrowheads. (B) Immunostaining offrac- 
tions 4 and 7 by IID8 monoclonal ntibody against SERCA 2 Ca 2+ pump. Data in (A) and (B) (50/.tg protein/lane) represent 34 microsome 
preparations. 
phorylation against hapsigargin i hibition by preincubation 
with Ca 2+ has been described previously by Sagara et al. [22]. 
This protection could be explained by a Ca2+-induced shift in 
the *E,--*E conformational equilibrium [15] to the calcium- 
bound E form of ATPase, since previous tudies have demon- 
strated the *E form to be responsible for thapsigargin binding 
[25,26]. Essential for this explanation was the observation that 
when enzyme turnover was allowed (i.e. the phosphorylation 
reaction continued beyond 1 s), the Ca2+-protective effect was 
lost. In contrast o these findings by Sagara et al. [22], 20 s 
phosphorylation was used in the present work both for those 
fractions which did (e.g. fraction 4) and those which did not 
(e.g. fraction 7) exhibit the Ca 2+ protection phenomenon. (In 
fact, an undiminished degree of protection was observed with 
phosphorylation times up to 120 s.) Ca2+-ATPase subtypes 
different from SERCA 1 would be expected to be present in 
adrenal chromaffin cells (see below). Clearly, further work on 
these cells will be necessary to determine the kinetic-conforma- 
tional basis of this Ca2+-protective effect against hapsigargin 
inhibition in terms of the ATPase catalytical cycle. 
Considerable evidence is available for thapsigargin being an 
equally potent inhibitor of all the SERCA pump subtypes 
known [10,17,23]. However, the results of the present work 
indicate that this lack of thapsigargin selectivity does not neces- 
sarily apply, under appropriate conditions, to measurements of 
Ca2÷-ATPase autophosphorylation. Such measurements offer 
a uniquely sensitive way of studying the properties of Ca z÷- 
ATPases in a range of cell types, including heterologous expres- 
sion systems (see e.g. [6,17,23,27]), and have been indispensable 
in understanding the catalytical cycle of these pumps. In human 
platelets, Papp et al. [6] have reported an about 10-fold higher 
thapsigargin sensitivity of the SERCA 2b E ~P, as compared to 
another Ca 2+ pump, later shown to represent SERCA 3 [27,28]. 
In contrast, in the present study the difference in thapsigargin 
sensitivity between the E~Ps observed in gradient fractions 4 
and 7 was 1000-fold (Fig. 4). Thus, under the conditions de- 
scribed here, one may speak of a true discrimination by thapsi- 
gargin between those particular E~P forms in the adrenal chro- 
maffin cells. 
A rather weak 80 kDa fragment, consistent with the presence 
of SERCA 3 [27], was observed upon tryptic digestion of frac- 
tion 7, but not fraction 4 (Fig. 5A). However, it is clear that the 
differential thapsigargin sensitivity of Ca>-ATPase E~Ps in 
these two fractions cannot be correlated to these different tryp- 
tic digestion patterns, since the dominant tryptic fragment sets 
were 56 and 35 kDa in each of the 2 fractions, and since these 
sets showed the same widely different sensitivity to thapsigargin 
as their corresponding, non-digested autophosphorylated pro- 
teins. Specifically, this presence of the 80 kDa (SERCA 3- 
specific) fragment in fraction 7, but not in fraction 4, strongly 
indicates that the apparently thapsigargin-insensitive (i.e. Ca 2÷- 
protected) E~ P species of fraction 4 cannot be identical with the 
E~P originating from SERCA 3, as described by Papp et al. [6]. 
The exact nature of SERCA isoenzymes present in the bo- 
vine adrenal chromaffin cells is not known. The 56-35 kDa 
tryptic digestion pattern may originate from SERCA 1 as well 
as SERCA 2 isoenzymes [26,29]. However, SERCA la/b forms 
are restricted to fast twitch muscle fibers [3]. Although SERCA 
2a has typically been found in slow twitch, cardiac and smooth 
muscle cells [3], a low level of expression of SERCA 2a (in 
addition to a high level of SERCA 2b) was noted by immunocy- 
tochemistry and Northern blotting in pig cerebellum [30]. In 
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contrast o the tissue-restricted xpression pattern of the other 
types, SERCA 2b is thought o occur ubiquitously [3]. Against 
this background, the 56 35 kDa tryptic fragments pattern in 
the adrenal medulla microsomal subfractions would be consis- 
tent with the presence of SERCA 2 class of isoenzymes. This 
conclusion is supported by the SERCA 2-like immunostaining 
with the IID8 monoclonal antibody in fractions 4 and 7. This 
antibody, raised against the dog cardiac sarcoplasmic reticulum 
Ca2+-ATPase (SERCA 2a) [24], has been shown to react with 
an epitope common to SERCA 2a and SERCA 2b isoenzymes 
in several species, including pig [29], rabbit [31] and rat [32]. 
Therefore, both the tryptic digestion and the immunological 
data suggest that in the present work, the differential sensitivity 
to thapsigargin of the 2 Ca2+-ATPase E -P  forms in bovine 
adrenal medulla microsomes reveals a new level of heterogene- 
ity within the SERCA 2 class of isoenzymes. 
The presence of such new molecular heterogeneity is further 
supported by clearly different distribution profiles of the Ca 2+- 
protected, and the thapsigargin-sensitive, E~P forms on the 
isopycnic sucrose gradient (Fig. 2). This difference in the distri- 
bution profiles strongly suggests differential localization of the 
two Ca 2+ pump forms in chromaffin cells. To our knowledge, 
these results represent the first evidence of such differential 
localization of SERCA subtypes in any cells of neural origin. 
It will be a challenging task to elucidate how these new facets 
of molecular diversity among Ca 2+ pumps translate to their 
specialized physiological functions. 
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